GENE ONLINE|News &
Opinion
Blog

FDA Approval
Trials & Approvals Hearing Loss
Fennec’s PEDMARK Finally Gains FDA Approval to Treat Chemo-Induced Hearing Loss
2022-09-22
Trials & Approvals Bristol Myers Squibb
BMS’s Once-Daily Plaque Psoriasis Treatment, Sotyktu, Gains FDA Approval to Rival Otezla
2022-09-12
Trials & Approvals Rare Disease
QOL Medical’s Sucraid Single-Use Containers Approved For Patients With Sucrase Deficiency
2022-09-07
Trials & Approvals AstraZenca
AstraZeneca’s Imfinzi Combination Becomes First Approved Immunotherapy Regimen For Biliary Tract Cancer
2022-09-06
Vertex’s Orkambi Racks Up Another Approval For Cystic Fibrosis
2022-09-05
Trials & Approvals Sanofi
Sanofi’s Rare Disease Drug Granted First-Ever FDA Approval for the Condition
2022-09-01
Go Prime FDA
Mounting Criticisms of FDA’s Accelerated Approval Pathway Could Prompt Changes to the System
2022-08-25
Trials & Approvals Menopause
Astellas Pharmaceuticals’ Novel Non-hormonal Treatment for Severe Symptoms of Menopause Approved by the FDA
2022-08-18
Trials & Approvals bluebird bio
Bluebird Bio’s Zynteglo Becomes First FDA-Approved Gene Therapy For Beta-Thalassemia
2022-08-18
Trials & Approvals Antiviral
FDA Approves Roche’s Established Antiviral For Children Aged Five Or Older
2022-08-12
First Targeted Therapy for HER2-Low Breast Cancer Approved by FDA
2022-08-05
Trials & Approvals KYZATREX
KYZATREX’s FDA Approval Adds to the Lineup of New Oral Testosterone Treatments
2022-08-03
Trials & Approvals FDA ApprovalPsoriatic Arthritis
Treatment Approved by FDA for Childhood Arthritis
2022-08-02
Trials & Approvals Crohn’s disease
Applications for Medicine Treating Crohn’s Disease Submitted to EMA and FDA
2022-07-29
Trials & Approvals FDA Approval
First Treatment Targeting ALS Genetic Cause Could be a Reality with FDA Approval
2022-07-27
1 2 3 4 5 … 9
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top